Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -11.60% is 70% above its 5-year average of -38.50%, near the high end of its 5-year range (-69.17%–4.37%).
53.90% above its 12-month average of -25.16%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -51.75%.
OPERATING MARGIN
-11.60%
OPERATING MARGIN AVG TTM
-25.16%
OPERATING MARGIN AVG 3Y
-28.21%
OPERATING MARGIN AVG 5Y
-38.50%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+53.90%
CURRENT VS 3Y AVG
+58.88%
CURRENT VS 5Y AVG
+69.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Health Catalyst, Inc.
Market Cap
$131.16M
Operating Margin
-11.60%
TTM Avg
-25.16%
3Y Avg
-28.21%
5Y Avg
-38.50%
Market Cap
$127.91M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
Market Cap
$134.74M
Operating Margin
-9.35%
TTM Avg
-5.78%
3Y Avg
-14.39%
5Y Avg
-45.18%
Market Cap
$135.50M
Operating Margin
-3.66%
TTM Avg
-13.20%
3Y Avg
-25.26%
5Y Avg
-22.69%
Market Cap
$122.89M
Operating Margin
-1853.92%
TTM Avg
-1829.87%
3Y Avg
-8864.53%
5Y Avg
-5959.13%
Market Cap
$141.09M
Operating Margin
-7.85%
TTM Avg
-2.10%
3Y Avg
-0.51%
5Y Avg
4.29%
Market Cap
$122.59M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$121.00M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $131.16M | -11.60% | -25.16% | -28.21% | -38.50% |
| Entera Bio Ltd. (ENTX)vs › | $127.91M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| LifeMD, Inc. (LFMD)vs › | $134.74M | -9.35% | -5.78% | -14.39% | -45.18% |
| KORU Medical Systems, Inc. (KRMD)vs › | $135.50M | -3.66% | -13.20% | -25.26% | -22.69% |
| Cibus, Inc. (CBUS)vs › | $122.89M | -1853.92% | -1829.87% | -8864.53% | -5959.13% |
| Freenome, Inc. (FRNM)vs › | $138.67M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $141.09M | -7.85% | -2.10% | -0.51% | 4.29% |
| enGene Holdings Inc. (ENGN)vs › | $122.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fortress Biotech, Inc. (FBIOP)vs › | $141.70M | -111.00% | -151.19% | -184.89% | -203.40% |
Gross Margin
33.5%
Operating Margin
-11.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -51.75% |
| 2026-03-31 | -9.54% |
| 2025-12-31 | 4.37% |
| 2025-09-30 | -22.94% |
| 2025-06-30 | -45.95% |
| 2025-03-31 | -25.40% |
| 2024-12-31 | -21.98% |
| 2024-09-30 | -17.93% |
| 2024-06-30 | -20.83% |
| 2024-03-31 | -30.53% |
| 2023-12-31 | -43.66% |
| 2023-09-30 | -33.32% |
| 2023-06-30 | -47.28% |
| 2023-03-31 | -47.27% |
| 2022-12-31 | -53.13% |
| 2022-09-30 | -66.89% |
| 2022-06-30 | -46.99% |
| 2022-03-31 | -35.76% |
| 2021-12-31 | -69.17% |
| 2021-09-30 | -68.43% |
| 2021-06-30 | -54.20% |
| 2021-03-31 | -43.54% |
| 2020-12-31 | -73.05% |
| 2020-09-30 | -49.71% |
| 2020-06-30 | -36.15% |
| 2020-03-31 | -40.13% |
| 2019-12-31 | -31.43% |
| 2019-09-30 | -52.60% |
| 2019-06-30 | -25.44% |
| 2019-03-31 | -31.51% |
| 2018-12-31 | -35.84% |
| 2018-09-30 | -50.19% |
| 2018-06-30 | -81.82% |
| 2018-03-31 | -57.46% |
